Internal Medicine, Hematology & Oncology · Elmhurst, NY
NPI
1477668572
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8806 55th Ave
Elmhurst, NY, 11373
Phone (855) 528-7322
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
95,978 services
Medicare patients, 2024
386
Average age 77
Drug cost, 2024
$12.3M
3,076 prescriptions
Company payments, 2025
$1,209
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Li-Teh Wu was code J1439 (injection, ferric carboxymaltose, 1 mg), 22,500 times for 19 patients. In total Li-Teh Wu billed 95,978 services in 160 codes, and Medicare paid $1.2M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 22,500 | 19 | $0.87 | $20K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 16,100 | 11 | $2.25 | $36K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,350 | 26 | $0.09 | $120 |
| 36415 Venipuncture Blood Collection | Office | 1,246 | 300 | $8.65 | $11K |
| 85025 Blood Count | Office | 1,178 | 297 | $7.61 | $8,965 |
| 88185 Surgical Pathology Examination | Office | 1,133 | 44 | $21.79 | $25K |
| 80053 Clinical Chemistry | Office | 971 | 279 | $10.35 | $10K |
| 83615 Clinical Chemistry | Office | 892 | 267 | $5.91 | $5,276 |
| 84100 Clinical Chemistry | Office | 784 | 244 | $4.65 | $3,642 |
| 83735 Clinical Chemistry | Office | 772 | 242 | $6.56 | $5,067 |
| 99214 Office E&M - Established | Office | 770 | 254 | $106.33 | $82K |
| 84550 Clinical Chemistry | Office | 767 | 242 | $4.43 | $3,394 |
| 82728 Clinical Chemistry | Office | 595 | 203 | $13.34 | $7,939 |
| 83540 Clinical Chemistry | Office | 542 | 186 | $6.33 | $3,431 |
| 83550 Clinical Chemistry | Office | 540 | 185 | $8.56 | $4,621 |
By year: 2022 $1.7M for 120,961 services; 2023 $699K for 73,181 services; 2024 $1.2M for 95,978 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,246 | 300 | $8.65 | $11K |
| 85025 Blood Count | 1,178 | 297 | $7.61 | $8,965 |
| 88185 Surgical Pathology Examination | 1,133 | 44 | $21.79 | $25K |
| 80053 Clinical Chemistry | 971 | 279 | $10.35 | $10K |
| 83615 Clinical Chemistry | 892 | 267 | $5.91 | $5,276 |
| 84100 Clinical Chemistry | 784 | 244 | $4.65 | $3,642 |
| 83735 Clinical Chemistry | 772 | 242 | $6.56 | $5,067 |
| 84550 Clinical Chemistry | 767 | 242 | $4.43 | $3,394 |
| 82728 Clinical Chemistry | 595 | 203 | $13.34 | $7,939 |
| 83540 Clinical Chemistry | 542 | 186 | $6.33 | $3,431 |
Medicare prescription drug claims, 2024
In 2024, the drug Li-Teh Wu prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 159 prescriptions and refills. In total Li-Teh Wu wrote 3,076 Medicare prescriptions that cost $12.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 159 | 161 | 37 | $426K |
| Akynzeo Fosnetupitant/Palonosetron | 158 | 158 | 34 | $152K |
| Famotidine Generic | 102 | 164 | 37 | $755 |
| Revlimid Lenalidomide | 101 | 101 | 11 | $1.6M |
| Exemestane Generic | 84 | 118 | 20 | $11K |
| Xgeva Denosumab | 76 | 88 | 15 | $233K |
| Anastrozole Generic | 74 | 159 | 21 | $934 |
| Raloxifene Hcl Generic | 67 | 138 | 18 | $1,429 |
| Ibrance Palbociclib | 64 | 64 | Under 11 | $991K |
| Procrit Epoetin Alfa | 55 | 55 | 15 | $126K |
| Prednisone Generic | 52 | 62 | 19 | $171 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 52 | 52 | Under 11 | $725K |
| Letrozole Generic | 49 | 128 | 21 | $1,009 |
| Pantoprazole Sodium Generic | 44 | 48 | 15 | $238 |
| Gabapentin Generic | 43 | 45 | 14 | $300 |
Brand drugs: - claims; generic drugs: 1,545 claims; opioid claims: 67.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Li-Teh Wu $1,209 ($1,209 in general payments such as food, travel and fees) from 5 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,000.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.